Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 08:30 am Purchase |
2025-04-10 | 13D | The Lovesac Company LOVE |
Anson Funds Management LP | 1,045,665 7.100% |
113,404 (+12.16%) |
Filing History |
| 2025-03-25 11:45 am Purchase |
2025-03-13 | 13D | The Lovesac Company LOVE |
Anson Funds Management LP | 932,261 6.000% |
117,898 (+14.48%) |
Filing History |
| 2025-02-14 7:10 pm Purchase |
2024-12-31 | 13G | Elevai Labs, Inc. Common Stock ELAB |
Anson Funds Management LP | 151,501 4.900% |
149,900 (+9364.25%) |
Filing History |
| 2025-02-14 6:36 pm Purchase |
2024-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Anson Funds Management LP | 225,271 7.100% |
225,271 (New Position) |
Filing History |
| 2025-02-14 6:32 pm Unchanged |
2024-12-31 | 13G | Cyngn Inc. CYN |
Anson Funds Management LP | 14,802 9.900% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:30 pm Purchase |
2024-12-31 | 13G | Oncolytics Biotech Inc. ONCY |
Anson Funds Management LP | 8,185,743 9.600% |
8,185,743 (New Position) |
Filing History |
| 2025-02-14 6:29 pm Purchase |
2024-12-31 | 13G | LogicMark, Inc. LGMK |
Anson Funds Management LP | 128,385 0.300% |
101,458 (+376.78%) |
Filing History |
| 2025-02-14 6:26 pm Purchase |
2024-12-31 | 13G | SRM Entertainment, Inc. SRM |
Anson Funds Management LP | 1,395,235 9.600% |
1,395,235 (New Position) |
Filing History |
| 2025-02-14 6:22 pm Purchase |
2024-01-31 | 13G | Digital Ally, Inc. DGLY |
Anson Funds Management LP | 576,541 9.900% |
576,541 (New Position) |
Filing History |
| 2025-02-14 5:24 pm Purchase |
2024-12-31 | 13G | Universe Pharmaceuticals INC UPC |
Anson Funds Management LP | 19,558 9.900% |
19,558 (New Position) |
Filing History |
| 2025-02-14 5:22 pm Purchase |
2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
Anson Funds Management LP | 411,681 2.100% |
346,111 (+527.85%) |
Filing History |
| 2025-02-14 5:16 pm Purchase |
2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
Anson Funds Management LP | 113,479 9.900% |
113,479 (New Position) |
Filing History |
| 2025-02-14 2:46 pm Purchase |
2024-12-31 | 13G | 22nd Century Group, Inc. XXII |
Anson Funds Management LP | 2,432,220 4.900% |
2,408,957 (+10355.49%) |
Filing History |
| 2025-02-14 2:11 pm Sale |
2024-12-31 | 13G | Meihua International Medical Technologies Co., Ltd. MHUA |
Anson Funds Management LP | 1,205,255 4.800% |
-1,062,046 (-46.84%) |
Filing History |
| 2025-02-14 11:48 am Purchase |
2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX |
Anson Funds Management LP | 367,950 1.400% |
361,564 (+5662.18%) |
Filing History |
| 2025-02-14 11:24 am Purchase |
2024-12-31 | 13G | Cemtrex, Inc. CETX |
Anson Funds Management LP | 90,554 4.900% |
35,259 (+63.76%) |
Filing History |
| 2025-02-14 07:08 am Purchase |
2024-12-31 | 13G | Cyngn Inc. CYN |
Anson Funds Management LP | 14,802 9.900% |
14,802 (New Position) |
Filing History |
| 2024-11-14 6:08 pm Purchase |
2024-09-30 | 13G | Meihua International Medical Technologies Co., Ltd. MHUA |
Anson Funds Management LP | 2,267,301 9.500% |
2,267,301 (New Position) |
Filing History |
| 2024-11-14 6:01 pm Purchase |
2024-09-30 | 13G | ZyVersa Therapeutics, Inc. ZVSA |
Anson Funds Management LP | 54,054 4.900% |
54,054 (New Position) |
Filing History |
| 2024-11-14 5:58 pm Purchase |
2024-09-30 | 13G | LogicMark, Inc. LGMK |
Anson Funds Management LP | 26,927 9.900% |
26,927 (New Position) |
Filing History |